Beijing Hotgen Biotech Co Ltd
SSE:688068
Operating Income
Forecast
Operating Income Estimate
Beijing Hotgen Biotech Co Ltd
For the last 5 years the
compound annual growth rate for
Beijing Hotgen Biotech Co Ltd's operating income is
102%.
The projected
CAGR
for the next 3 years is
-64%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Hotgen Biotech Co Ltd's stock price target?
Not Available
Beijing Hotgen Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Beijing Hotgen Biotech Co Ltd's Revenue forecast?
Projected CAGR
-59%
For the last 5 years the
compound annual growth rate for
Beijing Hotgen Biotech Co Ltd's revenue is
90%.
The projected
CAGR
for the next 3 years is
-59%.
What is Beijing Hotgen Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-64%
For the last 5 years the
compound annual growth rate for
Beijing Hotgen Biotech Co Ltd's operating income is
102%.
The projected
CAGR
for the next 3 years is
-64%.
What is Beijing Hotgen Biotech Co Ltd's Net Income forecast?
Projected CAGR
-59%
For the last 5 years the
compound annual growth rate for
Beijing Hotgen Biotech Co Ltd's net income is
99%.
The projected
CAGR
for the next 3 years is
-59%.
You don't have any saved screeners yet
